Press Release

A USD 0.98 Billion the Global Renal Denervation Market to Surge at a CAGR of Around 25.19 % During 2025-30

The Global Renal Denervation Market size was valued at around USD 0.98 billion in 2024 and is projected to reach USD 3.4 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 25.19% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in their recent research report. The primary utilization of the renal denervation procedure is to normalize blood pressure by a minimally invasive process that restrains the renal nerve activity. The high blood pressure controlled by this process eases the dealing with many health issues including, heart attacks, heart failures, CVD diseases, and hypertension.

The renal denervation industry is primarily driven by the high prevalence of CVD diseases across the globe. As per, the World Heart Federation report 2023, cardiovascular disease has affected around half a billion individuals in 2021. More than 20 million deaths were caused by cardiovascular disease in 2021, where around 11 million deaths were with high blood pressure as the main reason for CVD disease. Therefore, controlling high blood pressure through renal denervation is expected to boost the Renal Denervation Market.

Hypertension, the other major driving factor for renal denervation, affects more than 33% of adults around the globe. It is the primary concerning factor for most healthcare institutes and organizations as it leads to more than 8 million deaths every year, with stroke, renal disease, and vascular disease being indirect factors. Further, the cases of hypertension have increased by 140% in the Western Pacific and Southeast Asia region.

Moreover, with the rising number of chronic diseases & other major health problems, consumer health awareness & self-consciousness are on the rise. Therefore, in 2023, over 45% of consumers were consciously making decisions based on their health and personal well-being and preferred effective and appropriate treatments for their health issues. It is also estimated that around 80% of patients with hypertension are not effectively treated, and if treated properly, could prevent over 75 million deaths during the forecast period, further states the research report, Global Renal Denervation Market Analysis, 2025.”

Global Renal Denervation Market Segmentation Analysis

Radio Frequency Technology Holds the Largest Market Share

Based on the Technology Type, the market is further bifurcated into Radio-Frequency (RF), Ultrasound, Micro-Infusion, and others. The radio frequency (RF) based technology type dominates the market among all the major technologies in the Global Renal Denervation Market. Among the patients who are resistant to hypertension treatment, RF-based technology is widely recognized for its effectiveness in lowering blood pressure and dealing with hypertension. The Symplicity renal denervation device developed by Medtronic and a similar device by Abbott Technologies are recognized as very efficient in hypertension treatment, resulting in the highest market share of radio frequency technology in the market.

Europe to Lead the Renal Denervation Industry

Europe is projected to lead the Renal Denervation Industry with the largest market share. The largest market share is attributed to the efficient and strong healthcare infrastructure in the region, along with high incidences of hypertension, with supportive and strict regulatory frameworks. As per, the European Commission, more than 22% of the working population in Europe is dealing with the problem of high blood pressure, hypertension, etc., which is expected to further expand the market during the forecast period.

Competitive Landscape

With strategic initiatives such as mergers, collaborations, and acquisitions, the leading market companies, including Medtronic Plc, Boston Scientific Co., Otsuka Holdings Co. Ltd., ReCor Medical, Inc., Mercator Medsystems, Inc., Symple Surgical Inc., Kona Medical Inc., Terumo Corporation, Johnson & Johnson Pvt. Ltd., Ablative Solutions, Inc, Renal Dynamics Ltd., Abbott Laboratories, Miracor Medical SA, DeepQure Inc., SoniVie, and others are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the Globe?
4. How has the industry been evolving in terms of geography & product adoption?
5. How has the competition been shaping up across various regions?
6. How have buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2020-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?